Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Relationships between the Nicotine Metabolite Ratio and a Panel of Exposure and Effect Biomarkers: Findings from Two Studies of U.S. Commercial Cigarette Smokers.

Authors: Carroll, Dana M; Murphy, Sharon E; Benowitz, Neal L; Strasser, Andrew A; Kotlyar, Michael; Hecht, Stephen S; Carmella, Steve G; McClernon, Francis J; Pacek, Lauren R; Dermody, Sarah S; Vandrey, Ryan G; Donny, Eric C; Hatsukami, Dorothy K

Published In Cancer Epidemiol Biomarkers Prev, (2020 04)

Abstract: BACKGROUND: We examined the nicotine metabolite ratio's (NMR) relationship with smoking intensity, nicotine dependence, and a broad array of biomarkers of exposure and biological effect in commercial cigarette smokers. METHODS: Secondary analysis was conducted on two cross-sectional samples of adult, daily smokers from Wave 1 (2013-2014) of the Population Assessment of Tobacco Use and Health (PATH) Study and baseline data from a 2014-2017 randomized clinical trial. Data were restricted to participants of non-Hispanic, white race. The lowest quartile of NMR (<0.26) in the nationally representative PATH Study was used to distinguish slow from normal/fast nicotine metabolizers. NMR was modeled continuously in secondary analysis. RESULTS: Compared with slow metabolizers, normal/fast metabolizers had greater cigarettes per day and higher levels of total nicotine equivalents, tobacco-specific nitrosamines, volatile organic componds, and polycyclic aromatic hydrocarbons. A novel finding was higher levels of inflammatory biomarkers among normal/fast metabolizers versus slow metabolizers. With NMR modeled as a continuous measure, the associations between NMR and biomarkers of inflammation were not significant. CONCLUSIONS: The results are suggestive that normal/fast nicotine metabolizers may be at increased risk for tobacco-related disease due to being heavier smokers, having higher exposure to numerous toxicants and carcinogens, and having higher levels of inflammation when compared with slow metabolizers. IMPACT: This is the first documentation that NMR is not only associated with smoking exposure but also biomarkers of biological effects that are integral in the development of tobacco-related disease. Results provide support for NMR as a biomarker for understanding a smoker's exposure and potential risk for tobacco-related disease.

PubMed ID: 32051195 Exiting the NIEHS site

MeSH Terms: Adult; Biomarkers/blood; Biomarkers/metabolism; Biomarkers/urine; Cigarette Smoking/blood*; Cigarette Smoking/immunology; Cigarette Smoking/metabolism; Cigarette Smoking/urine; Cotinine/analogs & derivatives*; Cotinine/blood; Cotinine/metabolism; Cotinine/urine; Cross-Sectional Studies; Datasets as Topic; Female; Humans; Inflammation/blood; Inflammation/diagnosis; Inflammation/immunology; Inflammation/urine; Longitudinal Studies; Male; Middle Aged; Nicotine/blood*; Nicotine/metabolism; Nicotine/urine; Randomized Controlled Trials as Topic; Self Report/statistics & numerical data; Severity of Illness Index; Smokers/statistics & numerical data; Tobacco Use Disorder/blood; Tobacco Use Disorder/diagnosis*; Tobacco Use Disorder/immunology; Tobacco Use Disorder/urine; United States

to Top